12 – Improving Cancer Screening and Care in Native American Communities
Release Date: 09/18/2023
28 – Jack’s Journey with Multi-Cancer Early Detection
The Cancer SIGNAL
At a semiannual primary care visit, Jack’s doctor mentioned multi-cancer early detection (MCED) testing. Though Jack wasn’t experiencing symptoms, and has no family history of cancer, he decided to take the test. Two Cancer Signal Detected results from MCED screening tests taken six months apart helped his care team determine the necessary diagnostics that confirmed an early-stage cancer diagnosis. Listen to Jack’s story to learn more about the impact early cancer detection had on his life. Watch the full episode on YouTube: Help shape future episodes by taking our...
info_outline
27 – Multi-Cancer Early Cancer Detection at the Doctor’s Office
The Cancer SIGNAL
Dr. Patrick McGill was instrumental in introducing Community Health Network to multi-cancer early detection (MCED) testing and integrating it into routine screenings offered to patients. Dr. McGill is Executive Vice President and Chief Transformation Officer at Community Health Network, and as a practicing primary care physician he believes strongly in the importance of catching cancer as early as possible to improve outcomes for patients. In this episode he shares how MCED has made an impact at Community Health Network. Watch the full episode on YouTube: Help shape future...
info_outline
26 – The Role of Cancer Screening in Longevity
The Cancer SIGNAL
How does cancer screening fit into one’s longevity goals? Dr. Ummat, a preventative medicine physician dedicated to changing the approach to aging, shares insights on the role of preventative care in maintaining long-term health, why proactive screening matters, and how new technologies like multi-cancer early detection testing can change the way we screen for cancer. Watch the full episode on YouTube: Help shape future episodes by taking our survey: Transcripts: Sign up for GRAIL’s newsletter: The Galleri test does not detect a signal for all cancers. Not all...
info_outline
25 – Research Update on Multi-Cancer Early Detection with Dr. Eric Klein
The Cancer SIGNAL
Dr. Eric Klein, Distinguished Scientist at GRAIL, provides a research update from GRAIL’s 2024 findings on multi-cancer early detection (MCED) testing, presented at ASCO, ESMO, AACR and more. He explores insights from the first real-world evaluation of repeat multi-cancer early detection testing, data on how multi-cancer early detection (MCED) testing is helping cancer survivors by detecting recurrence and new cancers, and findings on using MCED to detect high grade, clinically significant prostate cancer over indolent cases. Plus, the economic and emotional impacts of cancer screening, and...
info_outline
24 – Rich and Staci’s Story with Multi-Cancer Early Detection
The Cancer SIGNAL
At their doctor’s recommendation, Rich and Staci each took a multi-cancer early detection test during a routine checkup. Despite having no symptoms, Rich received a Cancer Signal Detected result, while Staci, who had a strong family history of cancer, did not. Listen to their story and learn about the impact of early cancer detection. Watch the full episode on YouTube: View Rich and Staci’s story: Help shape future episodes by taking our survey: Transcripts: Sign up for GRAIL’s newsletter: The Galleri test does not detect a signal for all cancers....
info_outline
23 – Early Detection = Better Outcomes, with the Prevent Cancer Foundation
The Cancer SIGNAL
Seven in 10 Americans are behind on at least one routine cancer screening. Jody Hoyos, CEO of the Prevent Cancer Foundation, joins Susanna to discuss the critical role of early cancer detection. She addresses the most common misconceptions about cancer screening and explains the importance of proactive screening, even when no symptoms are present. Help shape future episodes by taking our survey: Transcripts: Sign up for GRAIL’s newsletter:
info_outline
22 – Meet Susanna Quinn, Ovarian Cancer Survivor and Our New Host
The Cancer SIGNAL
Introducing our new host, Susanna Quinn! Susanna is a cancer survivor, entrepreneur, writer and philanthropist. Diagnosed with stage three ovarian cancer in 2019, Susanna underwent aggressive treatment and achieved cancer-free status by September of the same year. In this episode, Kim Thiboldeaux, the Cancer SIGNAL’s inaugural host, interviews Susanna about her cancer story and passes the torch. Help shape future episodes by taking our survey: Transcripts: Sign up for GRAIL’s newsletter:
info_outline
21 – Overcoming Medical Mistrust, Bias, and Access to Cancer Screening in the LGBTQ+ Community
The Cancer SIGNAL
Dr. Scout, Executive Director of the National LGBT Cancer Network, discusses how the LGBTQ+ community faces unique challenges in cancer screening. Dr. Scout highlights the increased cancer risks due to social factors, like discrimination and medical mistrust, and emphasizes the importance of inclusive healthcare provider training. The National LGBT Cancer Network works to educate both the community and providers, runs support groups for LGBTQ+ cancer survivors, and is developing a more comprehensive list of welcoming providers. Help shape future episodes by taking our survey:...
info_outline
20 – Improving Cancer Screening in the LGBTQ+ Community
The Cancer SIGNAL
Jon Rendina and Dwight Venson of Whitman-Walker, a healthcare center historically focused on the LGBTQ+ community, join us to delve into how LGBTQ+ people and people of color face disparities in cancer incidence. Whitman-Walker, Cancer Support Community, and GRAIL are collaborating on INCLUDE, a study to evaluate multi-cancer early detection (MCED) testing’s impact within federally qualified health centers. The goal: make this kind of cancer screening available to more people in the future. Jon and Dwight discuss barriers to access, how LGTBQ+ and minority experiences of cancer care can be...
info_outline
19 – The Power of Diverse Representation in Clinical Trials
The Cancer SIGNAL
Diverse clinical trials provide more meaningful data to researchers, but too many trials are based around monolithic audience groups. In early disease detection, particularly in conditions like cancer, diversity in clinical trials is especially important. Our guests, Eucharia Borden of the cancer nonprofit Family Reach and Dr. Gary Puckrein of the National Minority Quality Forum, discuss why diversity in clinical trials is critical and how to foster inclusivity in clinical research, getting us closer to healthcare equity. Help shape future episodes by taking our survey: ...
info_outlineThe American Indian Cancer Foundation is on a mission to eliminate the cancer burdens of Indigenous people through improved access to prevention, early detection, treatment and survivor support. Melissa Buffalo, CEO of the Foundation, discusses the cancer burden faced by Native Americans and what her Foundation is doing to reduce disparities in care.
Transcripts available at https://grail.com/podcast/
Sign up for GRAIL’s newsletter: https://grail.com/newsletter-signup/